Is Universal Health Services (UHS) overvalued or fairly valued?

MarketChacha shows Universal Health Services's valuation in context — a trailing P/E of about 7.4, a forward P/E of about 7.0, a price-to-book of about 1.3 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does Universal Health Services's reported profit turn into cash?

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (1.55×) from reported figures — education, not a rating.

What is Universal Health Services's revenue?

Universal Health Services reported revenue of $17.4B for FY2025, with net profit of $1.5B, per official filings.

What is the share price of Universal Health Services (UHS)?

Universal Health Services last traded at $169.65 (+0.3% on the day), as of 9/4/2026 — a delayed quote shown for education, not investment advice.

Universal Health Services

UHS · NYSE · Healthcare · United States

Snapshot

TickerUHS

ExchangeNYSE

SectorHealthcare

IndustryMedical Care Facilities

CountryUnited States

Employees102,000

HeadquartersKing of Prussia, United States

Websiteuhs.com

Filings tracked18

About Universal Health Services

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capital resources; and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.

Who owns it

Insiders5.0%
Institutions95.0%
Public & other0.0%

839 institutional holders

Ownership breakdown from public market data.

Top holders

First Eagle Investment Management, LLC8.81%
Blackrock Inc.7.85%
Vanguard Capital Management LLC6.56%
Vanguard Portfolio Management LLC4.74%
Dimensional Fund Advisors LP4.28%
State Street Corporation4.07%
Geode Capital Management, LLC3.82%
Pzena Investment Management LLC3.81%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Cash conversion1.55×

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend5.0% → 8.6%

Margin has expanded by about 3.5 points — the business is getting more profitable.

Return on equity20.5%

Latest ROE of 20.5% — capital is generating a healthy return.

Growth qualityrev 10% · PAT 44%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $4.8B · EPS 5.66

Est. earnings growth -3.7%

Next fiscal year

Rev $19.5B · EPS 24.02

Est. earnings growth +6.6%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2025)

$17.4B

Net margin

8.6%

ROE

20.5%

Revenue CAGR (2y)

+10.3%

Profit CAGR (2y)

+44.0%

EPS (FY2025)

23.10

Net profit (FY2025)

$1.5B

Ask MarketChacha about UHS

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$17.4B	$1.5B	23.10	8.6%	20.5%
FY2024	$15.8B	$1.1B	16.82	7.2%	17.1%
FY2023	$14.3B	$717.8M	10.23	5.0%	11.7%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q2	$4.6B	$358.4M	5.98	7.7%
2026Q1	$4.5B	$348.7M	5.65	7.8%
2025Q3	$4.5B	$373.0M	5.86	8.3%
2025Q2	$4.3B	$353.2M	5.43	8.2%
2025Q1	$4.1B	$316.7M	4.80	7.7%
2024Q3	$4.0B	$258.7M	3.80	6.5%
2024Q2	$3.9B	$289.2M	4.26	7.4%
2024Q1	$3.8B	$261.8M	3.82	6.8%
2023Q3	$3.6B	$167.0M	2.40	4.7%
2023Q2	$3.5B	$171.3M	2.42	4.8%
2023Q1	$3.5B	$163.1M	2.28	4.7%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

10-Q filing
SEC8/7/2026
8-K — Results of operations, Exhibits
SEC7/28/2026material
8-K — Material agreement, Material financial obligation, Exhibits
SEC7/21/2026material
8-K — Shareholder vote results
SEC5/22/2026material
8-K — Executive/director change
SEC5/21/2026material
10-Q filing
SEC5/7/2026
8-K — Results of operations, Exhibits
SEC4/28/2026material
8-K — Material agreement, Material financial obligation, Exhibits
SEC4/24/2026material
8-K — Executive/director change
SEC3/30/2026material
8-K — Other events, Exhibits
SEC3/9/2026material
8-K — Results of operations, Other events, Exhibits
SEC2/26/2026material
10-K filing
SEC2/25/2026

2025

8-K — Executive/director change, Exhibits
SEC12/31/2025material
10-Q filing
SEC11/7/2025
8-K — Results of operations, Exhibits
SEC10/28/2025material
8-K — Other events
SEC9/29/2025material
10-Q filing
SEC8/8/2025
8-K — Results of operations, Exhibits
SEC7/29/2025material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.